Global bioprocess optimization and digital biomanufacturing market expected to grow, driven by various factors.
From GlobeNewswire: 2025-04-04 15:20:00
The global market for bioprocess optimization and digital biomanufacturing is projected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029, with a compound annual growth rate (CAGR) of 10.2%. Factors driving this growth include the rise in chronic diseases, demand for biopharmaceuticals, product launches, and government initiatives. Sensor technology and process analytical technology also play key roles in advancing the market.
A report from BCC Research segments the market by technology type, application, and molecule type, covering regions like North America, Europe, Asia-Pacific, and the Rest of the World. Key players in the market include Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific. The U.S. FDA has approved over 100 monoclonal antibodies for various diseases, and Industry 4.0 initiatives are driving innovation in the industry.
Emerging startups like Sexton Biotechnologies and iVexSol are revolutionizing bioproduction tools and viral vector manufacturing, respectively. The market is expected to dominate in analytical and process control technologies by 2029, with North America holding the largest market share. Various reports from BCC Research analyze market trends, dynamics, and emerging technologies in the biopharmaceutical industry, offering valuable insights for businesses and investors.
Read more at GlobeNewswire: Bioprocess Optimization and Digital Bio-manufacturing